| J2356 | Injection, tezepelumab-ekko, 1 mg | 14,280 | $10 | $199.9K |
| J2357 | Injection, omalizumab, 5 mg | 2,340 | $30 | $70.2K |
| J2182 | Injection, mepolizumab, 1 mg | 2,900 | $20 | $66.7K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1,550 | $30 | $52.7K |
| J1306 | Injection, inclisiran, 1 mg | 4,830 | $10 | $43.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 80 | $80 | $7.1K |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 20 | $120 | $1.8K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 170 | $10 | $1.5K |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 20 | $80 | $1.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 20 | $40 | $940 |